| abstract |
The present invention relates, generally, to oral administration of defensins for the treatment of intestinal diseases such as ulcerative colitis and Crohn's disease. The defensins are preferably human defensins, and are more preferably human α-defensins. The defensins may be provided in a dosage form that is suitable for oral administration to a patient suffering from intestinal disease. |